AU Patent

AU2015328174B2 — Modulators of cystic fibrosis transmembrane conductance regulator

Assigned to Vertex Pharmaceuticals Inc · Expires 2020-05-21 · 6y expired

What this patent protects

The present invention features a compound of formula (I): (I) or a pharmaceutically acceptable salt thereof, where R

USPTO Abstract

The present invention features a compound of formula (I): (I) or a pharmaceutically acceptable salt thereof, where R

Drugs covered by this patent

Patent Metadata

Patent number: AU2015328174B2
Jurisdiction: AU
Classification: —
Expires: 2020-05-21
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.